21-12-2022 08:00 via wallstreet-online.de

Poolbeg Identifies Novel RSV Drug Candidates

Poolbeg identifies new potential drug candidates for Respiratory Syncytial Virus infections as part of Artificial Intelligence ProgrammeCollaboration with OneThree Biotech identifies novel RSV treatmentsFirst time RSV drug candidates identified …
Weiterlesen »